In Qinghai Province, the Brassica campestris pollen preparation Qianlie-Kang-Pule'an-Tablets (QKPT) is traditionally used for BPH
therapy. However, the content of supposedly active phytosterols in QKPT is relatively
low at only 2.59%, necessitating high doses for successful therapy. Thus, a phytosterol
enriched (4.54%) refined extract (PE) was developed and compared with QKPT in a BPH
rat model. Six groups of animals (n = 8 each) – sham operated distilled water control,
castrated distilled water control, castrated QKPT 2.0 g/kg, castrated PE 0.1 g/kg,
castrated PE 0.2 g/kg, castrated PE 0.4 g/kg – were intragastrically treated with
the respective daily doses. Testosterone propionate (0.3 mg/day) was administered
to all castrated rats, while the sham operated group received placebo injections.
After 30 days, the animals were sacrificed and prostates as well as seminal vesicles
excised and weighted for calculating prostate (PI) and seminal vesicle indexes (SVI)
(organ weight g/100 g body weight). Compared with sham-operated controls, both PI
(p < 0.01) and SVI (p < 0.01) were significantly increased in all castrated rats.
After treatment with PE at 0.4 and 0.2 g/kg or QKPT at 2.0 g/kg per day, both indices
were significantly reduced (p < 0.01) as compared to the castrated distilled water
control. For PE at 0.1 g/kg per day only PI was significantly reduced (p < 0.05).
At the highest PE concentration of 0.4 g/kg per day both PI and SVI were also significantly
reduced when compared to QKPT (p < 0.05). Thus, both PE and QKPT demonstrated curative
effects against BPH in the applied animal model. In the highest dose at 0.4 g/kg per
day, PE was clearly superior to QKPT.
Keywords: Brassica campestris L., Brassicaceae, pollen, TCM, phytosterols, benign prostatic
hyperplasia